Skip to main content

Table 2 Quality and quantity of tumor lysate-loaded DCs

From: A pilot study of autologous tumor lysate-loaded dendritic cell vaccination combined with sunitinib for metastatic renal cell carcinoma

Patient ID Tumor lysate used for EP (mg) DCs used for EP (x107) Tumor lysate (mg)/ 107DCs Number of DCs injected Viability (%)
1802 15 29.5 0.51 1x107 82.9
1803 15 18.3 0.82 1x107 82.1
1806 20 17.1 1.17 1x107 92.8
1808 7 16.0 0.44 1x107 83.6
1812 20 20.1 1.00 1x107 89.0
1814 20 21.5 0.93 1x107 91.7
1817 20 20.0 1.00 1x107 87.5
1823 20 15.0 1.33 0.5 x107 92.4
  1. EP, electroporation.